You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intratumoral Injection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial (OH2 Injection)

Not yet recruiting
  • Solid Tumor
  • OH2 Injection
  • (no location specified)
Jul 12, 2023

Cutaneous Tumor, Malignant Solid Tumor Trial (JCXH-211 Injection)

Not yet recruiting
  • Cutaneous Tumor
  • Malignant Solid Tumor
  • JCXH-211 Injection
  • (no location specified)
Feb 13, 2023

Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • CNSI-Fe(II) 30 mg
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Sep 15, 2023

Advanced Solid Tumor Trial (SGN1)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Jan 30, 2023

Solid Tumor Trial (BS006 Injection)

Not yet recruiting
  • Solid Tumor
  • BS006 Injection
  • (no location specified)
Jul 3, 2023

Hepatocellular Carcinoma Trial (SynOV1.1, Atezolizumab)

Recruiting
  • Hepatocellular Carcinoma
  • SynOV1.1
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jan 31, 2023

Metastatic Solid Tumor, Colon Cancer, Nonsmall Cell Lung Cancer Trial in France, Switzerland, United Kingdom (1.0% IP-001 for

Recruiting
  • Metastatic Solid Tumor
  • +3 more
  • 1.0% IP-001 for Injection
  • Bordeaux, France
  • +9 more
Jan 26, 2023

Advanced Melanoma Trial in New York, Houston (LTX-315 in combination with pembrolizumab)

Recruiting
  • Advanced Melanoma
  • LTX-315 in combination with pembrolizumab
  • New York, New York
  • +7 more
Jan 23, 2023

Solid Tumor, Lymphoma Trial in Israel, United States (MK-2118 (IT), MK-2118 (SC), Pembrolizumab)

Completed
  • Solid Tumor
  • Lymphoma
  • MK-2118 (IT)
  • +2 more
  • La Jolla, California
  • +7 more
Jan 23, 2023

Metastasis, Solid Tumor Trial (Peptide Alarm Therapy (PAT))

Not yet recruiting
  • Metastasis
  • Solid Tumor
  • Peptide Alarm Therapy (PAT)
  • (no location specified)
Nov 2, 2022

Advanced Bladder Carcinoma Trial in Wuhan (OH2 injection)

Recruiting
  • Advanced Bladder Carcinoma
  • OH2 injection
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College of Huazhong University o
Aug 5, 2022

Lung Cancer, Nonsmall Cell, Lung Cancer, Lung Cancer, Small Cell Trial in United States (NanoPac (sterile nanoparticulate

Active, not recruiting
  • Lung Cancer, Nonsmall Cell
  • +3 more
  • NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
  • Gainesville, Florida
  • +3 more
Jan 9, 2023

Cutaneous Tumor, Malignant Solid Tumor Trial in Houston (JCXH-211)

Not yet recruiting
  • Cutaneous Tumor
  • Malignant Solid Tumor
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Sep 9, 2022

Solid Tumor, Advanced Cancer Trial in Wuxi (Oncolytic Virus Injection(RT-01))

Recruiting
  • Solid Tumor
  • Advanced Cancer
  • Oncolytic Virus Injection(RT-01)
  • Wuxi, Jiangsu, China
    Wuxi People's Hospital
Jan 19, 2022

Non-muscle-invasive Bladder Cancer Trial in Myrtle Beach, Nashville (AU-011, AU-011 in Combination with Medical Laser)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • AU-011
  • AU-011 in Combination with Medical Laser
  • Myrtle Beach, South Carolina
  • +1 more
Jul 29, 2022

Relapsed/Refractory Solid Tumor Malignancies or Lymphoma, Ovarian Cancer Trial in United States (mRNA-2416, Durvalumab)

Terminated
  • Relapsed/Refractory Solid Tumor Malignancies or Lymphoma
  • Ovarian Cancer
  • mRNA-2416
  • Durvalumab
  • Aurora, Colorado
  • +8 more
Jul 7, 2022

Cervical Cancer Trial (KRC-01, External Beam Radiation Therapy, cisplatin)

Not yet recruiting
  • Cervical Cancer
  • (no location specified)
Oct 5, 2022

Metastatic Melanoma Trial (PV-001-DC)

Not yet recruiting
  • Metastatic Melanoma
  • PV-001-DC
  • (no location specified)
Aug 4, 2022

Recurrent Human Papillomavirus Type 16 Associated Cancer Trial in Birmingham, Baltimore (HPV 16 TA-CIN)

Withdrawn
  • Recurrent Human Papillomavirus Type 16 Associated Cancer
  • HPV 16 TA-CIN
  • Birmingham, Alabama
  • +1 more
Nov 29, 2022

Advanced Solid Tumor, Sarcoma, HNSCC Trial in China (T3011)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • T3011
  • Hefei, Anhui, China
  • +18 more
Oct 30, 2022

Head Neck Cancer, Intratumoral Injection Trial in Chicago (RiMO-301)

Recruiting
  • Head Neck Cancer
  • Intratumoral Injection
  • Chicago, Illinois
    University of Illinois at Chicago
Apr 28, 2023

Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Duarte, Hackensack, Houston (SIRPant-M, External-beam

Not yet recruiting
  • Refractory Non-Hodgkin Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • SIRPant-M
  • External-beam radiotherapy (XRT)
  • Duarte, California
  • +2 more
Jul 21, 2023

Pancreatic Adenocarcinoma Trial in France (Gene Therapy product CYL-02, Gemcitabine)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • Clichy, France
  • +6 more
Oct 27, 2021

Advanced Malignant Solid Tumor, Extracranial Solid Tumor, Metastatic Malignant Solid Tumor Trial in Palo Alto (Anti-OX40

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Anti-OX40 Antibody BMS 986178
  • TLR9 Agonist SD-101
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Jun 13, 2022

Uterine Cervical Tumors Trial in Wuhan (BS-006)

Not yet recruiting
  • Uterine Cervical Neoplasms
  • BS-006
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jun 6, 2022